Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome — Stella

Home/Renal Replacement Therapy for Acute Kidney Injury in ICU/Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

View on ClinicalTrials.gov

Recruiting

Back to Renal Replacement Therapy for Acute Kidney Injury in ICU trials

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

Trial locations(10 sites)

France

CHU d'Angers, Angers

Hôpital Pellegrin, Bordeaux

Hôpital la cavale blanche, Brest

CHU Dupuytren 1, Limoges

Hôtel-Dieu, Nantes

CHR d'Orléans, Orléans

CH de Pau, Pau

Centre Urgences-Réanimations, Rennes

IUCT-O Hopital Purpan, Toulouse

Hôpital Bretonneau, Tours

Key details

Sponsor

University Hospital, Bordeaux

Enrollment target

~800 participants

Started

July 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.